Wayfinder Biosciences Analysis: $7M Raised
What is Wayfinder Biosciences?
Wayfinder Biosciences develops RNA-targeting small molecules to neutralize the toxic effects of disease genes. Their approach focuses on preventing harmful proteins from being produced by targeting their mRNA. This innovative method allows for the development of therapeutics for traditionally undruggable targets, impacting various disease areas.
Location
4000 Mason Rd, Seattle, Washington 98195, United States
Employees
11-50
Founded
2021
Product Features & Capabilities
- RNA-targeting small molecules that bind to mRNA
- Proprietary RNA-based sensors for drug discovery
- AI/ML screening for selective small molecules
- Scalable platform for quantitative insights
- Therapeutics targeting oncology and neurodegeneration.
Use Cases
Neutralize toxic effects of disease genes; Prevent production of harmful proteins; Develop therapeutics for oncology; Target undruggable disease areas; Collaborate on neurodegeneration programs.
How much Wayfinder Biosciences raised
Funding - $7M
See something that needs updating? Suggest edits to this profile.